What Multiple Myeloma With t(11;14) Should Be Classified Into in Novel Agent Era: Standard or Intermediate Risk?

OBJECTIVE: To investigate the prognostic value of t(11;14) for de novo multiple myeloma (MM) patients in novel agent era. METHODS: A total of 455 patients with fluorescence in situ hybridization (FISH), before treatments from three hospitals in China, were included in the study. All patients receive...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Wen, Du, Juan, Liu, Junru, Zhou, Huixing, Zhang, Zhiyao, Jian, Yuan, Yang, Guangzhong, Wang, Guorong, Tian, Ying, Li, Yanchen, Wu, Yin, Fu, Weijun, Li, Juan, Chen, Wenming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649769/
https://www.ncbi.nlm.nih.gov/pubmed/33194599
http://dx.doi.org/10.3389/fonc.2020.538126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649769/
https://www.ncbi.nlm.nih.gov/pubmed/33194599
http://dx.doi.org/10.3389/fonc.2020.538126

Ejemplares similares